ASCO 2023 | Integrating patients’ experiences in bladder cancer therapeutic decisions: challenges and solutions

Benjamin Garmezy, MD, Sarah Cannon Research Institute, Nashville, TN, discusses the challenges in effectively integrating patients’ experiences into therapeutic decisions in bladder cancer and how these can be addressed. One key challenge is the limited time available for discussions between healthcare professionals and patients, which can hinder the comprehensive exploration of patient perspectives. Additionally, the complexity of medical information and terminology may impede effective communication. To address these challenges, healthcare professionals can allocate sufficient time for discussions, employ patient-friendly language, and utilize decision aids or support tools. Moreover, fostering a culture of shared decision-making and actively involving patients in treatment planning can ensure that their voices are adequately represented and their preferences are considered. This interview took place at the American Society of Clinical Oncology (ASCO) 2023 Annual Congress in Chicago, IL.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.